Thomas Guimard, MD

CHD VENDEE
LA ROCHE / YON, Pays de la Loire, France

Disclosure(s): Gilead: Convention invitation; Menarini France: Hospitality; MSD: Hospitality; Pfizer: Advisor/Consultant; Shionogi BV: Hospitality

Presentation(s):

• 82 - Comparative Evaluation of Low Versus High Doses of Rifampin for the Treatment of Staphylococcal Bone and Joint Infections: an open-label, randomized, controlled non-inferiority trial (EVRIOS)

  Thursday, October 17, 2024
  10:30 AM – 10:45 AM US PT

• 587 - Impact of the infectious site infection with Staphylococcus aureus in Europe: results from the economics of the SALT study

  Saturday, October 19, 2024
  1:45 PM – 2:00 PM US PT